Market Commentary     28-Feb-25
Mid-Session
Market under pressure; IT shares plunge amid global cues
The key equity benchmarks traded with substantial losses in morning trade due to ongoing FII selling and concerns over the tariffs situation. The Nifty dropped below 22,300 level. IT shares declined for the seventh consecutive trading session.

At 10:25 IST, the barometer index, the S&P BSE Sensex, declined 829.69 points or 1.11% to 73,777. The Nifty 50 index dropped 260.65 points or 1.16% to 22,284.40.

The broader market underperformed frontline indices. The S&P BSE Mid-Cap index declined 1.86% and the S&P BSE Small-Cap index fell 1.96%.

The market breadth was weak. On the BSE, 617 shares rose and 2,947 shares fell. A total of 137 shares were unchanged.

SEBI Leadership Change:

Tuhin Kanta Pandey has been appointed as the 11th chairperson of the Securities and Exchange Board of India (SEBI) for a three-year term. The current Finance Secretary will replace Madhabi Puri Buch, who will complete her tenure as SEBI's first woman chairperson on Friday, February 28, 2025.

Buzzing Index:

The Nifty IT declined 3.66% to 37,521. The index dropped 9.51% in seven consecutive trading session.

Persistent Systems (down 5.08%), Tech Mahindra (down 4.65%), Coforge (down 4.25%), Mphasis (down 4.12%) and Wipro (down 3.99%) were the top losers. Among the other losers were HCL Technologies (down 3.57%), Infosys (down 3.26%), LTIMindtree (down 2.97%), Tata Consultancy Services (down 2.78%) and L&T Technology Services (down 2.27%) declined.

Stocks in Spotlight:

Tata Power Company shed 0.73%. The company announced that its a wholly owned subsidiary, TP Solar, has secured a contract worth Rs 632 crore from the Solar Energy Corporation of India (SECI) for the supply of 292.5 MWp domestic content requirement (DCR) solar modules.

Rail Vikas Nigam (RVNL) declined 2.25%. The company has received a Letter of Acceptance (LoA) from Central Railway for a project valued at Rs 135.66 crore.

Biocon fell 2%. The company has announced the launch of its GLP-1 peptide Liraglutide for diabetes and obesity in the United Kingdom (U.K.).

Previous News
  Tata Power Company Ltd eases for fifth straight session
 ( Hot Pursuit - 20-Jan-26   13:35 )
  RVNL emerges L1 for South Eastern Railway’s VSS project
 ( Hot Pursuit - 19-Jan-26   08:01 )
  RVNL successfully bids for South Eastern Railway project of Rs 87.55 cr
 ( Corporate News - 16-Jan-26   16:52 )
  Biocon Ltd rises for third straight session
 ( Hot Pursuit - 16-Jan-26   13:05 )
  Biocon concludes QIP issue of Rs 4,150 cr
 ( Corporate News - 15-Jan-26   12:10 )
  Tata Power Company to table results
 ( Corporate News - 15-Jan-26   11:40 )
  Biocon to hold board meeting
 ( Corporate News - 14-Jan-26   10:04 )
  Tata Power Company Ltd drops for fifth straight session
 ( Hot Pursuit - 09-Jan-26   13:35 )
  Tata Power commissions 400 / 220 kV TP Jalpura Khurja Transmission line and substation
 ( Corporate News - 09-Jan-26   10:44 )
  RVNL secures Rs 201-cr order from East Coast Railway
 ( Hot Pursuit - 09-Jan-26   07:59 )
  Stock Alert: Powergrid, RVNL, Sagar Cements. Astra Micorwave, Bharat Forge
 ( Market Commentary - Stock Alert 09-Jan-26   07:48 )
Other Stories
  Sensex jumps 330 pts; FMCG shares advance
  22-Jan-26   14:33
  Indices trade with small gains; media shares advance; VIX jumps 1.97%
  22-Jan-26   13:34
  Barometers trim most of gains; pharma snaps 9-day losses
  22-Jan-26   12:39
  Sensex jumps 297 pts; media shares in demand
  22-Jan-26   11:33
  Nifty tad above 25,300 level; PSU bank shares advance
  22-Jan-26   10:30
  Indices edge higher in early trade; breadth strong
  22-Jan-26   09:33
  Sensex drops over 299 pts; realty shares slide
  21-Jan-26   14:31
  Indices trade with minor cuts; consumer durables shares tumble; VIX zooms 7.93%
  21-Jan-26   13:34
  Barometers slide as volatility spikes; PSU Bank shares skid
  21-Jan-26   12:40
  Sensex slides 646 pts; private bank shares decline
  21-Jan-26   11:32
Back Top